Hongjie Hu is a seasoned investor and managing partner in the healthcare sector, currently holding the title of Managing Partner at Cathay Capital. Hongjie Hu has invested in various companies, including Ascend Gene & Cell Therapies, Ganymed Robotics, Moon Surgical, and TISSIUM, where Hongjie Hu also serves as a board member. Educated at Harvard Business School from 2006 to 2008 and Stanford University from 1998 to 1999 with a Master of Science in Engineering Management, Hongjie Hu combines extensive academic knowledge with practical investment experience.
Links